Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
17% Median Decrease In Polyp Burden, 75% Non-Progression Rate; Cohort 2 Shows 89% Non-Progressors And 29% Median Polyp Reduction; Potential First Therapeutic Option For FAP
Posted In: BDRX